IRBESARTAN; HYDROCHLOROTHIAZIDE (IRBESARTAN; HYDROCHLOROTHIAZIDE) — FDA Approval ANDA090815 (ZYDUS PHARMS USA INC)
IRBESARTAN; HYDROCHLOROTHIAZIDE (IRBESARTAN; HYDROCHLOROTHIAZIDE) — FDA Approval ANDA090815 (ZYDUS PHARMS USA INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: IRBESARTAN; HYDROCHLOROTHIAZIDE; Active ingredients: IRBESARTAN; HYDROCHLOROTHIAZIDE; Application number: ANDA090815.
| Brand name | IRBESARTAN; HYDROCHLOROTHIAZIDE |
|---|---|
| Active ingredients | IRBESARTAN; HYDROCHLOROTHIAZIDE |
| Application number | ANDA090815 |
| Sponsor | ZYDUS PHARMS USA INC |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | None (Tentative Approval) |
| Products in application | 3 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →